Delivery Order SPE2DB24D2205-SPE2DB25FEDGT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,468.28 to supply Zepbound 7.5 mg/0.5 mL pen injections on June 2, 2025, with completion targeted for June 3, 2025. This competitively awarded, non-set-aside order utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $8,677.45 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on May 30, 2025, with an ultimate completion date of June 2, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance...
- The Defense Logistics Agency (DLA) awarded a $36,746.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectables. The contract, which represents a child order under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $6,063.97 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The order is scheduled for ultimate completion by August 20, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $12,539.80 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on July 31, 2025. This firm fixed-price, competitively awarded delivery order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 1, 2025. The contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a $4,575.54 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. The order, which represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical, is scheduled for completion by September 16, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was...
- The Defense Logistics Agency awarded a delivery order valued at $12,661.98 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pen injections on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside restrictions, represents a continuation of the vendor's critical role in federal pharmaceutical procurement. The order will be fulfilled from AmerisourceBergen's location in...
- The Defense Logistics Agency awarded a delivery order valued at $6,921.52 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract, designated as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $17,981.60 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors (0.5 mL). This firm fixed-price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections valued at $7,625.80 on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed price, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single-line pharmaceutical supply delivery under a competitive procurement process, reflecting the agency's continued...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEDGTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $35,951.29 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on June 5, 2025, with completion targeted for June 6, 2025. This firm fixed-price delivery order, which is not set-aside, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child contract under a larger indefinite delivery vehicle with the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The Zepbound supply supports the Defense Health Agency and broader military healthcare programs, reflecting the contractor's extensive portfolio of pharmaceutical deliveries across therapeutic domains. AmerisourceBergen Drug Corp's competitive standing through open contracting demonstrates its capability to meet federal medical procurement requirements for specialized pharmaceutical products and supplies serving military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.0k | 6/5/25 |